Cambridge-based healthtech startup auryx has successfully secured $2 million in pre-seed funding to advance its innovative platform. Founded by an all-female team of scientists, the company aims to transform everyday earbuds into sophisticated, continuous health monitors. This technology leverages existing microphones to capture a wide range of physiological data without requiring new hardware or changes in user behavior.
A Novel Approach to Health Monitoring
auryx's platform operates by analyzing acoustic signatures generated by the heart, lungs, and blood flow in real time. This method sidesteps the limitations of common consumer wearables that rely on optical sensors to detect blood flow beneath the skin. By using sound, the technology provides a more robust and reliable stream of health information, even during physical activity.
Unlike optical sensors, which can lose accuracy with movement, especially at the wrist, acoustic sensing from the ear offers superior stability. The ear provides a cleaner and more consistent signal, enabling the capture of a broader set of physiological metrics. This allows for more comprehensive health tracking beyond what is currently available in the consumer market.
The technology can measure not only heart rate but also respiratory rate, cardiac output, and even blood pressure. These are metrics typically difficult to obtain accurately outside of a clinical environment with specialized equipment. auryx makes this advanced monitoring accessible by integrating its software into devices millions of people already use daily.
From University Research to Market Innovation
The company's foundation is built upon more than a decade of pioneering research conducted at the University of Cambridge. The founding team, CEO Erika Bondareva, CTO Kayla-Jade Butkow, and Chief Scientific Officer Professor Cecilia Mascolo, united their expertise to solve this problem. Their collective work at the intersection of machine learning and audio diagnostics paved the way for auryx's creation.
The founders recognized the vast potential of sound to carry clinically relevant health information that had been largely overlooked. They decided to transition their findings from academic research into a practical application with real-world impact. This vision is to make continuous health monitoring a seamless, background process for everyone.
Strategic Funding and Future Growth
The $2 million funding round was led by Celero Ventures, with significant participation from EWOR, Cambridge Enterprise Ventures, Vento, and PurposeTech. This investment underscores strong confidence in auryx's software-only approach and its potential to disrupt the digital health landscape. Investors highlighted the team's deep sector insight and the technology's scalability across billions of devices.
The capital injection will be strategically used to accelerate the company's growth and technological development. Key priorities include advancing hardware integration with earbud manufacturers, refining the platform's data models, and deepening commercial partnerships. The company is also actively expanding its engineering and commercial teams to support its ambitious roadmap.
auryx is poised to redefine the health monitoring sector by unlocking the latent potential of microphones in consumer electronics. By embedding its intelligent software into existing devices, the company removes major barriers to adoption and makes advanced health tracking accessible. This innovation represents a significant step toward a future where continuous, passive health monitoring becomes an effortless part of daily life.